Find Locations
For hours, walk-ins and appointments.Syphilis: Treponemal Antibodies, Treponema pallidum Particle Agglutination (TPPA)
CPT:
86780
|
|
| 86780 |
Synonyms
- Syphilis
- TPPA
- Treponemal
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL (Note: This volume does not allow for repeat testing.)
Container
Gel-barrier tube or serum transfer tube
Collection
Usual blood collection technique
Storage Instructions
Room temperature
Stability Requirements
Temperature | Period |
|---|---|
Room temperature | 14 days |
Refrigerated | 14 days |
Frozen | 14 days |
Freeze/thaw cycles | Stable x3 |
Causes for Rejection
Gross hemolysis; lipemia or visible microbial contamination; heat inactivated samples; specimens other than serum
Test Details
Use
This test detects antibodies to Treponema pallidum and can be used in conjunction with a nontreponemal assay to aid in the diagnosis of syphilis infection. This test is not recommended as a stand-alone test for general screening purposes for syphilis, nor should it be used to evaluate response to therapy. To screen for and diagnose syphilis infection, a reflex cascade that includes both RPR and a treponemal-specific assay should be utilized per current guidelines.
Limitations
As with all serological tests for syphilis, interpretation of results obtained with TPPA test must be used in conjunction with the patient's clinical symptoms, medical history and other clinical and/or laboratory findings. Treponemal antibodies typically remain detectable long term following infection and therefore should not be used to evaluate response to therapy.
The syphilis TPPA may be reactive in <1% of normal or healthy persons; these biological false-positive results are often transient and their cause is unknown.
Treponemal antibody tests may be reactive in persons exposed to yaws or pinta.
Samples from patients with HIV, leprosy, toxoplasmosis, H. pylori or drug addiction may on occasion produce false-positive or inconclusive results.
|
As with all serological tests for syphilis, interpretation of results obtained with TPPA test must be used in conjunction with the patient's clinical symptoms, medical history and other clinical and/or laboratory findings. Treponemal antibodies typically remain detectable long term following infection and therefore should not be used to evaluate response to therapy. The syphilis TPPA may be reactive in <1% of normal or healthy persons; these biological false-positive results are often transient and their cause is unknown. Treponemal antibody tests may be reactive in persons exposed to yaws or pinta. Samples from patients with HIV, leprosy, toxoplasmosis, H. pylori or drug addiction may on occasion produce false-positive or inconclusive results. As with all serological tests for syphilis, interpretation of results obtained with TPPA test must be used in conjunction with the patient's clinical symptoms, medical history and other clinical and/or laboratory findings. Treponemal antibodies typically remain detectable long term following infection and therefore should not be used to evaluate response to therapy. The syphilis TPPA may be reactive in <1% of normal or healthy persons; these biological false-positive results are often transient and their cause is unknown. Treponemal antibody tests may be reactive in persons exposed to yaws or pinta. Samples from patients with HIV, leprosy, toxoplasmosis, H. pylori or drug addiction may on occasion produce false-positive or inconclusive results. |
|
As with all serological tests for syphilis, interpretation of results obtained with TPPA test must be used in conjunction with the patient's clinical symptoms, medical history and other clinical and/or laboratory findings. Treponemal antibodies typically remain detectable long term following infection and therefore should not be used to evaluate response to therapy. The syphilis TPPA may be reactive in <1% of normal or healthy persons; these biological false-positive results are often transient and their cause is unknown. Treponemal antibody tests may be reactive in persons exposed to yaws or pinta. Samples from patients with HIV, leprosy, toxoplasmosis, H. pylori or drug addiction may on occasion produce false-positive or inconclusive results. As with all serological tests for syphilis, interpretation of results obtained with TPPA test must be used in conjunction with the patient's clinical symptoms, medical history and other clinical and/or laboratory findings. Treponemal antibodies typically remain detectable long term following infection and therefore should not be used to evaluate response to therapy. The syphilis TPPA may be reactive in <1% of normal or healthy persons; these biological false-positive results are often transient and their cause is unknown. Treponemal antibody tests may be reactive in persons exposed to yaws or pinta. Samples from patients with HIV, leprosy, toxoplasmosis, H. pylori or drug addiction may on occasion produce false-positive or inconclusive results. |
Methodology
Agglutination
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf